Ironwood Pharmaceuticals, Inc.
corporate_fare Company Profile
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for IRWD at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Ironwood Pharmaceuticals Confirms Revolving Credit Facility Maturity Date by Meeting Liquidity Conditions
- Annual Report Details Major Restructuring, R&D Setbacks, and Medicare Pricing Impact Despite Improved Net Income
- Ironwood Pharmaceuticals Reports Strong 2026 Outlook with Significant Revenue & EBITDA Growth, Advances Key Pipeline Asset
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$296.15M
Net Income
$24.02M
Diluted EPS
$0.15
Op. Cash Flow
$127.04M
Free Cash Flow
$127.01M
Operating Income
$98.5M
Cash & Equivalents
$215.46M
Debt / Equity
0.00×
Net Margin
8.1%
Shares Outstanding
163.06M sh
Source: 10-K · filed 2026-02-26 · accession 0001104659-26-020489
show_chartPrice Chart
Loading chart...
feed IRWD - Filings & News (Page 2)
IRWD
Mar 11, 2026, 7:05 AM EDT
Price at Filing:
$3.71
Real-time Price:
$4.60
Change:
+$0.890 (+24%)
Market Cap:
$778.089M
IRWD
Feb 26, 2026, 4:09 PM EST
Price at Filing:
$3.66
Real-time Price:
$4.60
Change:
+$0.940 (+26%)
Market Cap:
$778.089M
IRWD
Feb 25, 2026, 7:11 AM EST
Price at Filing:
$3.44
Real-time Price:
$4.60
Change:
+$1.16 (+34%)
Market Cap:
$778.089M